Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 11 of about 11 for Bell Laboratories, Inc
Company Exchange Symbol Last price Quote change Market cap
Berkshire Hathaway Inc. NYSE BRK.A 217,000.09 +760.09 (0.35%) 355.57B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
Berkshire Hathaway Inc. NYSE BRK.B 143.89 +0.86 (0.60%) 355.57B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
BERKSHIRE HATHAWAY A DL 5 ETR BRH 198,973.84 +2,003.25 (1.02%)
BERKSHIRE HATHAWAY A DL 5 FRA BRH 198,010.64 +2,716.55 (1.39%)
BERKSH. H.B NEW DL-,00333 FRA BRYN 131.61 -0.39 (-0.29%)
BERKSHIRE -DRN BVMF BERK34 466.20 +6.30 (1.37%)
Roche Holding Ltd. VTX ROG 263.20 -0.70 (-0.27%) 226.56B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 34.25 -0.08 (-0.23%) 236.15B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG FRA RHO5
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (Bearer Share) SWX RO 261.25 +0.25 (0.10%)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell